Bioplus Specialty Infusion Ca, Llc

Home Infusion Therapy Pharmacy



  
  19110 Van Ness Ave, Torrance
California, 90501-1101

 866-202-9552    866-794-4844
Bioplus Specialty Infusion Ca, Llc is a Home Infusion Therapy Pharmacy in Torrance, California. It is located at 19110 Van Ness Ave, Torrance and it's customer support contact number is 866-202-9552. The authorized person of Bioplus Specialty Infusion Ca, Llc is Kirk Nilson who is President of the pharmacy and his contact number is 866-202-9552. Active license number of Bioplus Specialty Infusion Ca, Llc is PHY54649 for Home Infusion Therapy Pharmacy in California. Bioplus Specialty Infusion Ca, Llc accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance.
Bioplus Specialty Infusion Ca, Llc is pharmacy-based, decentralized patient care organization with expertise in USP 797-compliant sterile drug compounding that provides care to patients with acute or chronic conditions generally pertaining to parenteral administration of drugs, biologics and nutritional formulae administered through catheters and/or needles in home and alternate sites. Extensive professional pharmacy services, care coordination, infusion nursing services, supplies and equipment are provided to optimize efficacy and compliance.


Pharmacy Details:
Bioplus Specialty Infusion Ca, Llc type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
Name: Bioplus Specialty Infusion Ca, Llc
Type: Home Infusion Therapy Pharmacy
Location:19110 Van Ness Ave, Torrance,
California, 90501-1101
Phone:866-202-9552
Fax:866-794-4844
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
Name: Kirk Nilson
Position: President
Contact Number: 866-202-9552
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
NPI Number: 1033135983
NPI Enumeration Date: 14 Jul, 2006
NPI Last Update On: 27 Oct, 2026

Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Bioplus Specialty Infusion Ca, Llc are as mentioned below.
SpecializationLicense NumberStateStatus
Home Infusion Therapy Pharmacy PHY54649CaliforniaPrimary
Durable Medical Equipment & Medical Supplies Secondary
Community/Retail Pharmacy PHY54649CaliforniaSecondary
Medicare Enrollment:
Bioplus Specialty Infusion Ca, Llc is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
PAC ID: Enrollment ID: Org NameMedicare Entity Type
7719033919O20100930073141Kroger Specialty Infusion Ca, LlcDME SUPPLIER - PHARMACY
Products Available:
Bioplus Specialty Infusion Ca, Llc has following products available for sale under medicare.
Products:
•  Infusion Pumps & Supplies: External Infusion•  Infusion Pumps & Supplies: Insulin Infusion
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: Po Box 746260,
Atlanta, Georgia
Zip: 30374-6260
Phone Number: 866-202-9552
Fax Number: 866-794-4844
Patients can reach Bioplus Specialty Infusion Ca, Llc at 19110 Van Ness Ave, Torrance, California or can call on customer care at 866-202-9552.
Comments/ Reviews:
Read all the reviews posted for Bioplus Specialty Infusion Ca, Llc below. You may also share your own experience with Bioplus Specialty Infusion Ca, Llc. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 November, 2026.